![Jeff Caravella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Caravella
Direttore Finanziario/CFO presso
ABIOMED, INC.
Profilo
Jeff Caravella is currently Chief Financial Officer at ABIOMED, Inc. since 2025.
Formerly, Mr. Caravella was Chief Financial Officer at BioTheryX, Inc. and Chief Financial Officer at Medicenna Therapeutics Corp.
in 2023.
Education includes undergraduate and MBAistration degrees from Syracuse University.
Posizioni attive di Jeff Caravella
| Società | Posizione | Inizio |
|---|---|---|
| ABIOMED, INC. | Direttore Finanziario/CFO | 01/01/2025 |
Precedenti posizioni note di Jeff Caravella
| Società | Posizione | Fine |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Direttore Finanziario/CFO | 26/10/2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Direttore Finanziario/CFO | - |
Formazione di Jeff Caravella
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
